Diagnostic accuracy of a serotype-specific antigen test in community-acquired pneumonia

European Respiratory Journal

Volumn 42, Issue 5, 2013, Pages 1283-1290

  Huijts, Susanne M ^a   Pride, Michael W ^b   Vos, Josephine M I ^c   Jansen, Kathrin U ^b   Webber, Chris ^d   Gruber, William ^e   Boersma, Wim G ^f   Snijders, Dominic ^f   Kluytmans, Jan A J W ^g   Van Der Lee, Ivo ^h   Kuipers, Bart A F ⁱ   Van Der Ende, Arie ^j   Bonten, Marc J M ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b Pfizer Vaccine Research Operations and Strategy   (United States)

^c ST ANTONIUS HOSPITAL   (Netherlands)

^d PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United Kingdom)

^e Pfizer Vaccine Research and Development   (United States)

^f Location Alkmaar   (Netherlands)

^g AMPHIA HOSPITAL   (Netherlands)

^h Infection and Immunology   (Netherlands)

ⁱ Isala Klinieken   (Netherlands)

^j ACADEMIC MEDICAL CENTER   (Netherlands)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; PNEUMOCOCCUS VACCINE;

ADULT; AGED; ANTIGEN DETECTION; ARTICLE; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; BLOOD CULTURE; CHRONIC COUGH; COHORT ANALYSIS; COMMUNITY ACQUIRED PNEUMONIA; CONTROLLED STUDY; COUGHING; DIAGNOSTIC ACCURACY; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DYSPNEA; ESCHERICHIA COLI INFECTION; FEMALE; FEVER; HAEMOPHILUS INFLUENZAE; HUMAN; HYPOTHERMIA; HYPOXIA; KLEBSIELLA; LEGIONELLA PNEUMOPHILA; LOWER RESPIRATORY TRACT INFECTION; LUNG INFILTRATE; MAJOR CLINICAL STUDY; MALE; MORAXELLA CATARRHALIS; OBSERVATIONAL STUDY; PREVALENCE; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SENSITIVITY AND SPECIFICITY; SEROTYPE; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIA; STREPTOCOCCUS PNEUMONIAE; TACHYPNEA; THORAX RADIOGRAPHY; URINALYSIS; URINARY ANTIGEN DETECTION;

AGED; ANTIGENS, BACTERIAL; COMMUNITY-ACQUIRED INFECTIONS; FEMALE; HUMANS; MALE; MIDDLE AGED; PNEUMONIA, PNEUMOCOCCAL; POLYSACCHARIDES; PREVALENCE; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 84887305712     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00137412     Document Type: Article

References (32)

1. Woodhead MA, Macfarlane JT, McCracken JS, et al. Prospective study of the aetiology and outcome of pneumonia in the community. Lancet 1987; 1: 671-674.
2. Jokinen C, Heiskanen L, Juvonen H, et al. Microbial etiology of community-acquired pneumonia in the adult population of 4 municipalities in eastern Finland. Clin Infect Dis 2001; 32: 1141-1154.
3. Hausdorff WP, Bryant J, Paradiso PR, et al. Which pneumococcal serogroups cause the most invasive disease: implications for conjugate vaccine formulation and use, part I. Clin Infect Dis 2000; 30: 100-121.
4. Harboe ZB, Thomsen RW, Riis A, et al. Pneumococcal serotypes and mortality following invasive pneumococcal disease: A population-based cohort study. PLoS Med 2009; 6: e1000081.
5. Campbell SG, Marrie TJ, Anstey R, et al. The contribution of blood cultures to the clinical management of adult patients admitted to the hospital with community-acquired pneumonia: A prospective observational study. Chest 2003; 123: 1142-1150.
6. van de Garde EM, Endeman H, van Hemert RN, et al. Prior outpatient antibiotic use as predictor for microbial aetiology of community-acquired pneumonia: hospital-based study. Eur J Clin Pharmacol 2008; 64: 405-410.
7. Metersky ML, Ma A, Bratzler DW, et al. Predicting bacteremia in patients with community-acquired pneumonia. Am J Respir Crit Care Med 2004; 169: 342-347.
8. Rosón B, Carratalà J, Verdaguer R, et al. Prospective study of the usefulness of sputum Gram stain in the initial approach to community-acquired pneumonia requiring hospitalization. Clin Infect Dis 2000; 31: 869-874.
9. Ewig S, Schlochtermeier M, Goke N, et al. Applying sputum as a diagnostic tool in pneumonia: limited yield, minimal impact on treatment decisions. Chest 2002; 121: 1486-1492.
10. Gutiérrez F, Masiá M, Rodríguez JC, et al. Evaluation of the immunochromatographic Binax NOW assay for detection of Streptococcus pneumoniae urinary antigen in a prospective study of community-acquired pneumonia in Spain. Clin Infect Dis 2003; 36: 286-292.
11. Marcos MA, Jiménez de Anta MT, de la Bellacasa JP, et al. Rapid urinary antigen test for diagnosis of pneumococcal community-acquired pneumonia in adults. Eur Respir J 2003; 21: 209-214.
12. Domínguez J, Galí N, Blanco S, et al. Detection of Streptococcus pneumoniae antigen by a rapid immunochromatographic assay in urine samples. Chest 2001; 119: 243-249.
13. Hak E, Grobbee DE, Sanders EA, et al. Rationale and design of CAPITA: A RCT of 13-valent conjugated pneumococcal vaccine efficacy among older adults. Neth J Med 2008; 66: 378-383.
14. Pride MW, Huijts SM, Wu K, et al. Validation of an immunodiagnostic assay for detection of 13 Streptococcus pneumoniae serotype-specific polysaccharides in human urine. Clin Vaccine Immunol 2012; 19: 1131-1141.
15. Austrian R. The quellung reaction, a neglected microbiologic technique. Mt Sinai J Med 1976; 43: 699-709.
16. Lund E, Henrichsen J. Laboratory diagnosis, serology and epidemiology of Streptococcus pneumoniae. Methods Microbiol 1978; 12: 241-262.
17. Fine MJ, Auble TE, Yealy DM, et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med 1997; 336: 243-250.
18. Dochez AR, Avery OT. The elaboration of specific soluble substance by pneumococcus during growth. J Exp Med 1917; 26: 477-493.
19. Leeming JP, Cartwright K, Morris R, et al. Diagnosis of invasive pneumococcal infection by serotype-specific urinary antigen detection. J Clin Microbiol 2005; 43: 4972-4976.
20. Scott JA, Hannington A, Marsh K, et al. Diagnosis of pneumococcal pneumonia in epidemiological studies: evaluation in Kenyan adults of a serotype-specific urine latex agglutination assay. Clin Infect Dis 1999; 28: 764-769.
21. Stralin K, Kaltoft MS, Konradsen HB, et al. Comparison of two urinary antigen tests for establishment of pneumococcal etiology of adult community-acquired pneumonia. J Clin Microbiol 2004; 42: 3620-3625.
22. Sheppard CL, Harrison TG, Smith MD, et al. Development of a sensitive, multiplexed immunoassay using xMAP beads for detection of serotype-specific Streptococcus pneumoniae antigen in urine samples. J Med Microbiol 2011; 60: 49-55.
23. da Gloria Carvalho M, Pimenta FC, Jackson D, et al. Revisiting pneumococcal carriage by use of broth enrichment and PCR techniques for enhanced detection of carriage and serotypes. J Clin Microbiol 2010; 48: 1611-1618.
24. Huebner RE, Dagan R, Porath N, et al. Lack of utility of serotyping multiple colonies for detection of simultaneous nasopharyngeal carriage of different pneumococcal serotypes. Pediatr Infect Dis J 2000; 19: 1017-1020.
25. Kaltoft MS, Skov Sørensen UB, Slotved HC, et al. An easy method for detection of nasopharyngeal carriage of multiple Streptococcus pneumoniae serotypes. J Microbiol Methods 2008; 75: 540-544.
26. Brandileone MCDC, Vieira VSD, Casagrande ST, et al. Prevalence of serotypes and antimicrobial resistance of Streptococcus pneumoniae strains isolated from Brazilian children with invasive infections. Pneumonococcal Study Group in Brazil for the SIREVA Project. Regional System for Vaccines in Latin America. Microb Drug Resist 1997; 3: 141-146.
27. Cockrell SL, Ruegsegger JM. Multiple pneumococcus infections in pneumonia. J Infect Dis 1941; 68: 33-36.
28. Bewick T, Sheppard C, Greenwood S, et al. Serotype prevalence in adults hospitalised with pneumococcal noninvasive community-acquired pneumonia. Thorax 2012; 67: 540-545.
29. Smith MD, Derrington P, Evans R, et al. Rapid diagnosis of bacteremic pneumococcal infections in adults by using the Binax NOW Streptococcus pneumoniae urinary antigen test: A prospective, controlled clinical evaluation. J Clin Microbiol 2003; 41: 2810-2813.
30. Andreo F, Prat C, Ruiz-Manzano J, et al. Persistence of Streptococcus pneumoniae urinary antigen excretion after pneumococcal pneumonia. Eur J Clin Microbiol Infect Dis 2009; 28: 197-201.
31. Hohenthal U, Vainionpää R, Meurman O, et al. Aetiological diagnosis of community acquired pneumonia: utility of rapid microbiological methods with respect to disease severity. Scand J Infect Dis 2008; 40: 131-138.
32. van der Eerden MM, Vlaspolder F, de Graaff CS, et al. Value of intensive diagnostic microbiological investigation in low- and high-risk patients with community-acquired pneumonia. Eur J Clin Microbiol Infect Dis 2005; 24: 241-249.